Publication | Open Access
Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study
92
Citations
14
References
2021
Year
Lanadelumab demonstrated sustained efficacy and acceptable tolerability with long-term use in HAE patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1